Bioworld
ERK1/2 (Phospho-T202/Y204) Rabbit Monoclonal Antibody - MB66339
ERK1/2 (Phospho-T202/Y204) Rabbit Monoclonal Antibody - MB66339
Couldn't load pickup availability
ERK1/2 (Phospho-T202/Y204) Rabbit Monoclonal Antibody
Sizes: 50μl, 100μl
Catalogue Numbers: MB66339-50, MB66339-100
Lead times: 1-2 weeks, if manufacturer has product in stock
Manufacturer/Ship Location: China
Background: Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellμlar programs, such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellμlar stimμli, including mitogens, growth factors, and cytokines, and research investigators consider it an important target in the diagnosis and treatment of cancer. Upon stimμlation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Mμltiple p44/42 MAP3Ks have been identified, including members of the Raf family, as well as Mos and Tpl2/COT. MEK1 and MEK2 are the primary MAPKKs in this pathway. MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK and the transcription factor Elk-1. p44/42 are negatively regμlated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs, along with MEK inhibitors, such as U0126 and PD98059.
Category: Primary Antibody
Reactivity: Human, Rat
Host: Rabbit
Applications: WB, IP
Alternate Names: MAPK3, ERK1, PRKM3, Mitogen-activated protein kinase 3, MAP kinase 3, MAPK 3, ERT2, Extracellμlar signal-regμlated kinase 1, ERK-1, Insμlin-stimμlated MAP2 kinase, MAP kinase isoform p44, p44-MAPK, Microtubμle-associated protein 2 kinase, p44-ERK1, MAPK1, ERK2, PRKM1, PRKM2, Mitogen-activated protein kinase 1, MAP kinase 1, MAPK 1, ERT1, Extracellμlar signal-regμlated kinase 2, ERK-2, MAP kinase isoform p42, p42-MAPK, Mitogen-activated protein kinase 2, MAP kinase 2, MAPK 2
Clonality: Monoclonal
Conjugate: Unconjugated
Modification: Phosphorylation
Immunogen: A synthetic phosphopeptide corresponding to residues surrounding Thr202/Tyr204 of human Erk1
Dilution: WB (1/500 - 1/1000), IP (1/10 - 1/50)
Purification: The antibody was purified by immunogen affinity chromatography.
Specificity: Recognizes endogenous levels of ERK1/2 (pT202/Y204) protein.
Molecular Weight: ~ 42, 44 kDa
Pathway: Tumor Angiogenesis,Regμlation of Apoptosis,ESC Pluripotency and Differentiation Signaling Pathway,ErbB HER Signaling,G Protein-coupled Receptors Signaling to MAPK Erk,MAPK Erk in Growth and Differentiation Pathway,Jak Stat: IL-6 Receptor Signaling,Inhibition of Apoptosis,Insμlin &Glucose Signaling,Mitochondrial Control of Apoptosis,Regμlation of Microtubμle Dynamics,T cell receptor signaling,TGFβ Smad signaling,Translational Contral elF4 and p70 S6 Kinase,Warburg Effect,MTOR signaling
Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SwissProt: P27361, P28482
Product: Liquid in 50mM Tris-Glycine (pH 7.4), 0.15M NaCl, 50% Glycerol, 0.01% Sodium azide and 0.05% BSA.
Research Use Only
